Affini-T Therapeutics, a biotech with roots at Fred Hutch, raises $175M for cancer treatments
March 22, 2022 at 17:50 PM EDT
The company, which has research labs in Seattle, is focusing on cell therapies for solid tumor cancers.
|
||||||||||||
![]() |
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |